TrialBritish journal of cancer2012

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer.

J Harder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.